Showing 1951-1960 of 23132 results for "".
The Nation's Drug Czar Discusses Opioid Addiction Interventions
https://reachmd.com/programs/conversations-on-health-care/nations-drug-czar-discusses-opioid-addiction-interventions/8011/This week, hosts Mark Masselli and Margaret Flinter speak with Michael Botticelli, Director of the Office of National Drug Control Policy at the White House. The nation's "Drug Czar" talks about ONDCP's quest to battle the rising tide of opioid addiction and overdoses, now the leading cause of accidAntibiotic Resistance: Encouraging Appropriate Use of Antibiotics
https://reachmd.com/programs/FDA-Drug-Information-Updates/antibiotic-resistance-encouraging-appropriate-use-antibiotics/7908/Antibiotic resistance is a growing public health concern worldwide. FDA Drug Info Rounds pharmacists discuss how the nation’s pharmacists can encourage the appropriate use of antibiotics. Learn more of the FDA Drug Info Rounds.Fostering Innovation in American vs. British Health Care Systems
https://reachmd.com/programs/conversations-on-health-care/fostering-innovation-american-vs-british-health-care-systems/7755/This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Harpreet Sood, Sr. Fellow to the CEO of the National Health Service of England. Dr. Sood addresses the strengths of the health systems of both the UK and the US, and discusses innovations in care delivery and public health initiativeThe Supreme Court Weighs in on the Affordable Care Act
https://reachmd.com/programs/conversations-on-health-care/supreme-court-weighs-affordable-care-act/7400/This week, hosts Mark Masselli and Margaret Flinter speak with Henry J. Aaron, the Bruce and Virginia MacLaury Senior Fellow in the Economic Studies program at the Brookings Institution. He analyzes the case before the Supreme Court, King versus Burwell, which challenges the legality of the tax subsRates of Obesity Leveling Off in Children
https://reachmd.com/programs/world-medical-news/rates-of-obesity-leveling-off-in-children/7115/Dr. Leuchars discusses how the rates of obesity in children ages 6 to 18 in the USA are remaining the same, according to a recent study.The 25th Anniversary of the Discovery of the Hepatitis C Virus: Looking Back to Look Forward
https://reachmd.com/programs/grand-rounds-nation/CDC-Hepatitis/7028/Twenty-five years ago CDC played a pivotal role in the discovery of the virus that causes hepatitis C. After the isolation of HCV, implementation of screening of blood products and organs for donation led to a decrease in rates of HCV infection between 1990 and 2009. In spite of these successes, HCVWhy I Left Medicine: A Young Doctor's Views on Burnout and Non-Clinical Transitions
https://reachmd.com/programs/your-career-in-healthcare/why-i-left-medicine-a-young-doctors-views-on-burnout-and-non-clinical-transitions/6994/Host Tim Rush welcomes Diane Shannon, MD, MPH, to discuss her decision to leave medicine and her perspectives on modern practice challenges such as the often times silent epidemic of burnout. She has grown to help other physicians practice medicine in a way that is positively affirming both for theUniversity of Arizona - Approaches in Congestive Heart Failure, Part 1
https://reachmd.com/programs/grand-rounds-nation/university-of-arizona-approaches-in-congestive-heart-failure-part-1/6446/Presenting this session of Grand Rounds is Dr. Mark J. Friedman, clinical professor of medicine and director of the Heart Failure Program at the University of Arizona. This is Part 1 of a lecture in three parts. Part 2 >> Part 3 >> To view the complete video recording of this and other GThe Battle Continues Against Pharmacological Cheating in Sports
https://reachmd.com/programs/focus-on-sports-medicine/the-battle-continues-against-pharmacological-cheating-in-sports/5324/Even after steroids scandals in Major League Baseball and more than 30 athletes were withheld from the winter Olympics in Vancouver for breaking anti-doping rules, why do athletes still engage in pharmacological cheating? The latest concern among sport officials is a new erythropoietin called HematiWhat Biotech Companies Want in Generic Legislation
https://reachmd.com/programs/clinicians-roundtable/what-biotech-companies-want-in-generic-legislation/4795/There appears to be movement in the US to bring less expensive versions of biotech drugs to market. But the brand name drug industry wants these so-called biosimilars to adhere to rigorous safety and efficacy standards currently not built into US laws. Tom DiLenge, vice president and general counsel